The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis
James C Keith, Leo M Albert, Yelena Leathurby, Max Follettie, Lili Wang, Lisa Borges-Marcucci, Christopher C Chadwick, Robert J Steffan and Douglas C Harnish*